The central melanocortin system directly controls peripheral lipid metabolism.

Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab (2011) 3.68

Human genetics illuminates the paths to metabolic disease. Nature (2009) 2.74

Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest (2012) 2.12

The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev (2010) 2.09

Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation. Cell Metab (2009) 1.98

Leptin and the central nervous system control of glucose metabolism. Physiol Rev (2011) 1.94

Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes (2012) 1.91

Central nervous system control of metabolism. Nature (2012) 1.83

SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab (2010) 1.64

Obesity accelerates thymic aging. Blood (2009) 1.59

Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology (2012) 1.58

Mouse models of the metabolic syndrome. Dis Model Mech (2010) 1.55

Genetic approaches to understanding human obesity. J Clin Invest (2011) 1.50

Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab (2012) 1.46

Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab (2008) 1.45

Hypothalamic POMC Deficiency Improves Glucose Tolerance Despite Insulin Resistance by Increasing Glycosuria. Diabetes (2015) 1.45

Retracted Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein. J Neurosci (2013) 1.44

Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence. Am J Physiol Regul Integr Comp Physiol (2008) 1.41

Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes (2008) 1.39

α-MSH Stimulates Glucose Uptake in Mouse Muscle and Phosphorylates Rab-GTPase-Activating Protein TBC1D1 Independently of AMPK. PLoS One (2016) 1.37

Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. Diabetes (2012) 1.28

Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci (2010) 1.25

Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann N Y Acad Sci (2011) 1.22

Challenges and opportunities of defining clinical leptin resistance. Cell Metab (2012) 1.21

Metabolic consequences and vulnerability to diet-induced obesity in male mice under chronic social stress. PLoS One (2009) 1.19

Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. Hum Hered (2013) 1.17

Loss of autophagy in hypothalamic POMC neurons impairs lipolysis. EMBO Rep (2012) 1.17

Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J (2012) 1.17

The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes (2011) 1.16

Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J Exp Med (2011) 1.15

Lower metabolic rate in individuals heterozygous for either a frameshift or a functional missense MC4R variant. Diabetes (2008) 1.12

Leanness and heightened nonresting energy expenditure: role of skeletal muscle activity thermogenesis. Am J Physiol Endocrinol Metab (2014) 1.10

Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology (2008) 1.08

Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes (2008) 1.07

Evidence that multiple genetic variants of MC4R play a functional role in the regulation of energy expenditure and appetite in Hispanic children. Am J Clin Nutr (2009) 1.07

Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle. FASEB J (2009) 1.07

Melanocortin-4 receptor-regulated energy homeostasis. Nat Neurosci (2016) 1.05

Hypothalamic mechanisms in cachexia. Physiol Behav (2010) 1.04

Ghrelin enhances olfactory sensitivity and exploratory sniffing in rodents and humans. J Neurosci (2011) 1.04

Genetic and epigenetic control of metabolic health. Mol Metab (2013) 1.03

Neural innervation of white adipose tissue and the control of lipolysis. Front Neuroendocrinol (2014) 1.02

CNS leptin action modulates immune response and survival in sepsis. J Neurosci (2010) 1.01

Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. Am J Pathol (2011) 1.01

The role of GNAS and other imprinted genes in the development of obesity. Int J Obes (Lond) (2009) 1.00

High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney. Dis Model Mech (2012) 1.00

Central melanocortin stimulation increases phosphorylated perilipin A and hormone-sensitive lipase in adipose tissues. Am J Physiol Regul Integr Comp Physiol (2010) 0.98

Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis. J Biol Chem (2011) 0.98

Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J (2011) 0.97

Melanocortin-3 receptor regulates the normal fasting response. Proc Natl Acad Sci U S A (2012) 0.97

Nutrient-sensing hypothalamic TXNIP links nutrient excess to energy imbalance in mice. J Neurosci (2011) 0.97

Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system. Diabetes (2012) 0.96

Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta (2013) 0.96

Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies. J Lipid Res (2013) 0.96

Gamma-protocadherins regulate the functional integrity of hypothalamic feeding circuitry in mice. Dev Biol (2009) 0.93

New central targets for the treatment of obesity. Br J Clin Pharmacol (2009) 0.93

Ultraviolet B stimulates proopiomelanocortin signalling in the arcuate nucleus of the hypothalamus in mice. Exp Dermatol (2016) 0.92

Ribosomal S6K1 in POMC and AgRP Neurons Regulates Glucose Homeostasis but Not Feeding Behavior in Mice. Cell Rep (2015) 0.92

GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors. Hum Mol Genet (2011) 0.91

Science of self-preservation: how melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage. Circulation (2009) 0.91

NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell Metab (2011) 0.91

Innervation of skeletal muscle by leptin receptor-containing neurons. Brain Res (2010) 0.90

Contributions of adipocyte lipid metabolism to body fat content and implications for the treatment of obesity. Curr Opin Pharmacol (2010) 0.90

The role of melanocortin neuronal pathways in circadian biology: a new homeostatic output involving melanocortin-3 receptors? Obes Rev (2009) 0.89

Homeostastic and non-homeostatic functions of melanocortin-3 receptors in the control of energy balance and metabolism. Physiol Behav (2011) 0.88

Effects of deficiency of the G protein Gsα on energy and glucose homeostasis. Eur J Pharmacol (2011) 0.87

Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. PLoS One (2013) 0.87

Gsα deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gsα mutations. Endocrinology (2012) 0.87

Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine. J Neurosci (2011) 0.87

Implications of gene-behavior interactions: prevention and intervention for obesity. Obesity (Silver Spring) (2008) 0.86

TXNIP in Agrp neurons regulates adiposity, energy expenditure, and central leptin sensitivity. J Neurosci (2012) 0.86

Pro-opiomelanocortin gene transfer to the nucleus of the solitary track but not arcuate nucleus ameliorates chronic diet-induced obesity. Neuroscience (2010) 0.86

Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis. J Physiol (2016) 0.85

Conditional expression of Pomc in the Lepr-positive subpopulation of POMC neurons is sufficient for normal energy homeostasis and metabolism. Endocrinology (2015) 0.85

More than satiety: central serotonin signaling and glucose homeostasis. Cell Metab (2007) 0.85

Postnatal changes in the expression pattern of the imprinted signalling protein XLαs underlie the changing phenotype of deficient mice. PLoS One (2012) 0.84

Melanocortin-3 receptors and metabolic homeostasis. Prog Mol Biol Transl Sci (2013) 0.84

Neuropeptide Y and agouti-related peptide mediate complementary functions of hyperphagia and reduced energy expenditure in leptin receptor deficiency. Endocrinology (2011) 0.83

Variation at the melanocortin 4 receptor gene and response to weight-loss interventions in the diabetes prevention program. Obesity (Silver Spring) (2013) 0.82

Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway. Proc Natl Acad Sci U S A (2014) 0.82

Neuroanatomical determinants of the sympathetic nerve responses evoked by leptin. Clin Auton Res (2012) 0.82

Melanocortin-4 receptor expression in different classes of spinal and vagal primary afferent neurons in the mouse. J Comp Neurol (2012) 0.82

The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus. J Signal Transduct (2013) 0.81

The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes. Int J Endocrinol (2015) 0.81

Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Future Sci OA (2015) 0.81

AgRP neurons: a switch between peripheral carbohydrate and lipid utilization. EMBO J (2012) 0.81

Reprogramming the body weight set point by a reciprocal interaction of hypothalamic leptin sensitivity and Pomc gene expression reverts extreme obesity. Mol Metab (2016) 0.81

Heparanase affects food intake and regulates energy balance in mice. PLoS One (2012) 0.80

Metabolic transceivers: in tune with the central melanocortin system. Trends Endocrinol Metab (2012) 0.80

Nr4a1 siRNA expression attenuates α-MSH regulated gene expression in 3T3-L1 adipocytes. Mol Endocrinol (2011) 0.80

A Functional Link between AMPK and Orexin Mediates the Effect of BMP8B on Energy Balance. Cell Rep (2016) 0.80

Deletion of Nhlh2 results in a defective torpor response and reduced Beta adrenergic receptor expression in adipose tissue. PLoS One (2010) 0.80

Unravelling the mysterious roles of melanocortin-3 receptors in metabolic homeostasis and obesity using mouse genetics. Int J Obes Suppl (2014) 0.80

Approach to assessing determinants of glucose homeostasis in the conscious mouse. Mamm Genome (2014) 0.79

Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats. Am J Physiol Endocrinol Metab (2012) 0.79

The HPA axis modulates the CNS melanocortin control of liver triacylglyceride metabolism. Physiol Behav (2011) 0.79

Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin. Neuropsychopharmacology (2013) 0.78

Hypothalamic KLF4 mediates leptin's effects on food intake via AgRP. Mol Metab (2014) 0.78

Regulation of lean mass, bone mass, and exercise tolerance by the central melanocortin system. PLoS One (2012) 0.78

Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling. Regul Pept (2009) 0.78

Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations. J Clin Invest (2016) 0.77

METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem (1964) 21.04

Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell (1997) 11.35

Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science (2004) 8.58

Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell (2005) 7.04

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med (2003) 6.87

Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (1997) 6.80

Anatomy and regulation of the central melanocortin system. Nat Neurosci (2005) 6.60

NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science (2005) 6.55

The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell (2003) 5.59

Obesity wars: molecular progress confronts an expanding epidemic. Cell (2004) 5.29

Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet (2000) 4.57

Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci (2005) 4.44

A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet (1998) 4.13

A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet (1998) 4.06

Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 3.00

A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology (2000) 2.90

Central melanocortin receptors regulate insulin action. J Clin Invest (2001) 2.83

Hypothalamic sensing of fatty acids. Nat Neurosci (2005) 2.67

White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am J Physiol Regul Integr Comp Physiol (2006) 2.55

Central insulin action in energy and glucose homeostasis. J Clin Invest (2006) 2.51

Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron (1998) 2.46

Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue. Am J Physiol Regul Integr Comp Physiol (2005) 2.23

Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. Endocrinology (2003) 2.14

Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci (2003) 2.14

Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J (2005) 2.03

Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest (2006) 2.03

A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci U S A (2000) 2.02

Neuronal activation in the hypothalamus and brainstem during feeding in rats. Cell Metab (2006) 2.01

Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest (2004) 1.74

Agouti-related protein increases food hoarding more than food intake in Siberian hamsters. Am J Physiol Regul Integr Comp Physiol (2003) 1.74

Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology (2006) 1.72

New developments in tracing neural circuits with herpesviruses. Virus Res (2005) 1.72

Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue. Endocrinology (2006) 1.71

The melanocortin system and energy balance. Peptides (2006) 1.64

FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J Biol Chem (2006) 1.56

Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci (2003) 1.55

Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med (2007) 1.51

Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes (2006) 1.46

Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab (2002) 1.46

A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab (2006) 1.46

Dietary free and esterified cholesterol absorption in cholesterol esterase (bile salt-stimulated lipase) gene-targeted mice. J Biol Chem (1996) 1.45

Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J Lipid Res (1999) 1.40

Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res (1980) 1.40

Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension (2004) 1.39

Protection against diet-induced obesity and obesity- related insulin resistance in Group 1B PLA2-deficient mice. Am J Physiol Endocrinol Metab (2002) 1.30

Brain-adipose tissue cross talk. Proc Nutr Soc (2005) 1.29

Gut peptide signaling in the controls of food intake. Obesity (Silver Spring) (2006) 1.22

Sympathetic but not sensory denervation stimulates white adipocyte proliferation. Am J Physiol Regul Integr Comp Physiol (2006) 1.19

Beta(1)/beta(2)/beta(3)-adrenoceptor knockout mice are obese and cold-sensitive but have normal lipolytic responses to fasting. FEBS Lett (2002) 1.17

Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue. Am J Physiol (1992) 1.09

Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes (2002) 1.07

Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats. Endocrinology (1986) 1.04

Differential responses of yellow Avy/A and agouti A/a (BALB/c X VY) F1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. Int J Obes (1988) 1.04

Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats. Am J Physiol Regul Integr Comp Physiol (2001) 1.03

Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake. Endocrinology (2005) 1.02

Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia (1994) 0.99

Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression. J Endocrinol (2004) 0.96

Gut peptides in the control of food intake: 30 years of ideas. Physiol Behav (2004) 0.94

Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes. Obes Res (2005) 0.94

The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. J Neuroendocrinol (2003) 0.94

Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes (1994) 0.90

Principles for interpreting interactions among the multiple systems that influence food intake. Am J Physiol Regul Integr Comp Physiol (2002) 0.88

The brain is getting ready for dinner. Cell Metab (2006) 0.88

Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity. J Med Chem (2006) 0.87

Melanocortin-4 receptors, beta-MSH and leptin: key elements in the satiety pathway. Peptides (2005) 0.86

Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats. Diabetologia (2005) 0.85

Dual innervation of white adipose tissue: some evidence for parasympathetic nervous system involvement. J Clin Invest (2002) 0.83

MC4R neurons weigh in differently. Nat Neurosci (2006) 0.80

Recent advances in obesity: adiposity signaling and fat metabolism in energy homeostasis. Adv Psychosom Med (2006) 0.78

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science (2007) 9.86

The GPR54 gene as a regulator of puberty. N Engl J Med (2003) 9.54

Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest (2007) 8.71

Hypothalamic mTOR signaling regulates food intake. Science (2006) 8.62

Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet (2012) 6.97

Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med (2003) 6.87

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83

Genetics of obesity in humans. Endocr Rev (2006) 5.42

Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A (2008) 5.21

Large, rare chromosomal deletions associated with severe early-onset obesity. Nature (2009) 5.20

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest (2005) 4.81

Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci (2006) 4.25

Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest (2011) 4.17

An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care (2007) 4.14

High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology (2010) 4.11

UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature (2008) 3.91

PPAR gamma and human metabolic disease. J Clin Invest (2006) 3.83

A guide to analysis of mouse energy metabolism. Nat Methods (2011) 3.82

Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest (2006) 3.81

Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab (2008) 3.80

The hormonal control of food intake. Cell (2007) 3.61

A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science (2004) 3.54

Significant linkage of BMI to chromosome 10p in the U.K. population and evaluation of GAD2 as a positional candidate. Diabetes (2006) 3.51

International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48

Leptin regulates striatal regions and human eating behavior. Science (2007) 3.31

Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet (2010) 3.21

Modernising medical careers, medical training application service, and the postgraduate medical education and training board: time for the emperors to don their clothes. Lancet (2007) 3.12

Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab (2008) 2.89

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest (2003) 2.87

Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes (2006) 2.87

Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab (2008) 2.86

Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med (2008) 2.86

Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res (2007) 2.83

Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat Med (2008) 2.78

Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med (2010) 2.76

Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73

Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest (2007) 2.73

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology (2002) 2.72

Cloned mice have an obese phenotype not transmitted to their offspring. Nat Med (2002) 2.68

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature (2012) 2.67

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes (2011) 2.65

Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet (2013) 2.63

Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes (2012) 2.62

Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes (2006) 2.62

A mutation in the thyroid hormone receptor alpha gene. N Engl J Med (2011) 2.62

A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet (2012) 2.60

Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci U S A (2004) 2.57

KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell (2013) 2.56

Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med (2007) 2.56

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. J Biol Chem (2007) 2.55

Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest (2009) 2.53

Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab (2008) 2.53

Monogenic obesity in humans. Annu Rev Med (2005) 2.53

Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology (2011) 2.45

Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology (2005) 2.43

GOAT links dietary lipids with the endocrine control of energy balance. Nat Med (2009) 2.42

Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes (2008) 2.41

A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology (2013) 2.39

Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol (2012) 2.39

A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci (2004) 2.39

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology (2007) 2.37

A knockin mouse model of the Bardet-Biedl syndrome 1 M390R mutation has cilia defects, ventriculomegaly, retinopathy, and obesity. Proc Natl Acad Sci U S A (2007) 2.36

A role for central nervous system PPAR-γ in the regulation of energy balance. Nat Med (2011) 2.34

Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes (2008) 2.33

Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation (2002) 2.30

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes (2003) 2.28

The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab (2010) 2.26

Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci (2012) 2.26

Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes (2005) 2.24